scholarly journals DeepMHCII: A Novel Binding Core-Aware Deep Interaction Model for Accurate MHC II-peptide Binding Affinity Prediction

2021 ◽  
Author(s):  
Ronghui You ◽  
Wei Qu ◽  
Hiroshi Mamitsuka ◽  
Shanfeng Zhu

Computationally predicting MHC-peptide binding affinity is an important problem in immunological bioinformatics. Recent cutting-edge deep learning-based methods for this problem are unable to achieve satisfactory performance for MHC class II molecules. This is because such methods generate the input by simply concatenating the two given sequences: (the estimated binding core of) a peptide and (the pseudo sequence of) an MHC class II molecule, ignoring the biological knowledge behind the interactions of the two molecules. We thus propose a binding core-aware deep learning-based model, DeepMHCII, with binding interaction convolution layer (BICL), which allows integrating all potential binding cores (in a given peptide) and the MHC pseudo (binding) sequence, through modeling the interaction with multiple convolutional kernels. Extensive empirical experiments with four large-scale datasets demonstrate that DeepMHCII significantly outperformed four state-of-the-art methods under numerous settings, such as five-fold cross-validation, leave one molecule out, validation with independent testing sets, and binding core prediction. All these results with visualization of the predicted binding cores indicate the effectiveness and importance of properly modeling biological facts in deep learning for high performance and knowledge discovery. DeepMHCII is publicly available at https://weilab.sjtu.edu.cn/DeepMHCII/.

Immunology ◽  
2018 ◽  
Vol 154 (3) ◽  
pp. 394-406 ◽  
Author(s):  
Kamilla Kjaergaard Jensen ◽  
Massimo Andreatta ◽  
Paolo Marcatili ◽  
Søren Buus ◽  
Jason A. Greenbaum ◽  
...  

2009 ◽  
Vol 36 (5) ◽  
pp. 289-296 ◽  
Author(s):  
Lian Wang ◽  
Danling Pan ◽  
Xihao Hu ◽  
Jinyu Xiao ◽  
Yangyang Gao ◽  
...  

2003 ◽  
Vol 9 (9-12) ◽  
pp. 220-225 ◽  
Author(s):  
Matthew N Davies ◽  
Clare E Sansom ◽  
Claude Beazley ◽  
David S Moss

2015 ◽  
Vol 67 (11-12) ◽  
pp. 641-650 ◽  
Author(s):  
Massimo Andreatta ◽  
Edita Karosiene ◽  
Michael Rasmussen ◽  
Anette Stryhn ◽  
Søren Buus ◽  
...  

2021 ◽  
Author(s):  
David R. Bell ◽  
Serena H. Chen

Antigen-specific immunotherapies (ASI) require successful loading and presentation of antigen peptide into the major histocompatibility complex (MHC) binding cleft. One route of ASI design is to mutate native antigens for either stronger or weaker binding interaction to MHC. Exploring all possible mutations is costly both experimentally and computationally. To reduce experimental and computational expense, here we investigate the minimal amount of prior data required to accurately predict the relative binding affinity of point mutations for peptide-MHC class II (pMHCII) binding. Using data from different residue subsets, we interpolate pMHCII mutant binding affinities by Gaussian process (GP) regression of residue volume and hydrophobicity. We apply GP regression to an experimental dataset from the Immune Epitope Database, and theoretical datasets from NetMHCIIpan and Free Energy Perturbation calculations. We find that GP regression can predict binding affinities of 9 neutral residues from a 6-residue subset with an average R2 coefficient of determination value of 0.62 ± 0.04 (± 95% CI), average error of 0.09 ± 0.01 kcal/mol (± 95% CI), and with an ROC AUC value of 0.92 for binary classification of enhanced or diminished binding affinity. Similarly, metrics increase to an R2 value of 0.69 ± 0.04, average error of 0.07 ± 0.01 kcal/mol, and an ROC AUC value of 0.94 for predicting 7 neutral residues from an 8-residue subset. Our work finds that prediction is most accurate for neutral residues at anchor residue sites without register shift. This work holds relevance to predicting pMHCII binding and accelerating ASI design.


2019 ◽  
Vol 20 (3) ◽  
pp. 170-176 ◽  
Author(s):  
Zhongyan Li ◽  
Qingqing Miao ◽  
Fugang Yan ◽  
Yang Meng ◽  
Peng Zhou

Background:Protein–peptide recognition plays an essential role in the orchestration and regulation of cell signaling networks, which is estimated to be responsible for up to 40% of biological interaction events in the human interactome and has recently been recognized as a new and attractive druggable target for drug development and disease intervention.Methods:We present a systematic review on the application of machine learning techniques in the quantitative modeling and prediction of protein–peptide binding affinity, particularly focusing on its implications for therapeutic peptide design. We also briefly introduce the physical quantities used to characterize protein–peptide affinity and attempt to extend the content of generalized machine learning methods.Results:Existing issues and future perspective on the statistical modeling and regression prediction of protein– peptide binding affinity are discussed.Conclusion:There is still a long way to go before establishment of general, reliable and efficient machine leaningbased protein–peptide affinity predictors.


IUBMB Life ◽  
1999 ◽  
Vol 48 (5) ◽  
pp. 483-491 ◽  
Author(s):  
Subhashini Arimilli ◽  
Irina Astafieva ◽  
Prabha V. Mukku ◽  
Cristina Cardoso ◽  
Shrikant Deshpande ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document